Last updated: August 23, 2024
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Failure (Pediatric)
Kidney Stones
Treatment
N/AClinical Study ID
NCT00588562
11-001702
1U54DK083908-01
Ages < 100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Individuals must have a definitive diagnosis of Primary Hyperoxaluria, Dent Disease,Cystinuria or APRT Deficiency.
Individuals have a family history of a sibling with Primary Hyperoxaluria,DentDisease, Cystinuria or APRT Deficiency.
Exclusion
Exclusion Criteria:
- Individuals who do not have Primary Hyperoxaluria, Dent Disease, Cystinuria or APRTDeficiency.
Study Design
Total Participants: 730
Study Start date:
July 01, 2003
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
APRT Registry - Landspitali Universtiy Hospital
Reykjavik,
IcelandActive - Recruiting
Dent Disease Registry -Mayo Clinic
Rochester, Minnesota 55905
United StatesActive - Recruiting
Primary Hyperoxaluria Registry - Mayo Clinic
Rochester, Minnesota 55905
United StatesActive - Recruiting
Cystinuria Registry - New York University
New York, New York 10010
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.